Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo

Abstract

There is a large body of evidence suggesting the connexin gap junction proteins appear to act as tumor suppressors, and their tumor inhibitory effect is usually attributed to their main function of cell coupling through gap junctions. However, some cancer cells (e.g. the rat bladder carcinoma BC31 cell line) are cell–cell communication proficient. Using specific site-directed mutagenesis in the third membrane-spanning (3M) domain of connexin43 (Cx43), we abolished the intrinsic gap junction intercellular communication (GJIC) in BC31 cells either by closing the gap junctional channels or by disruption of the transport of connexin complexes to the lateral membrane. Clones of BC31 cells transfected with a dominant negative Cx43 mutant giving rise to gap junctional channels, permeable only for a small tracer (neurobiotin), displayed accelerated growth rate in vivo, showing the critical role of selective gap junctional permeability in the regulation of cell growth in vivo. The use of other dominant-negative mutants of Cx43 also suggested that the effect of impaired communication on the tumorigenicity of cancer cells depends on the subcellular location of connexin. Inhibition of intrinsic GJIC in BC31 cells by sequestering of Cx protein inside the cytoplasm, due to expression of dominant-negative transport-deficient Cx43 mutants, did not significantly enhance the growth of transfectants in nude mice, but occasionally slightly retarded it. In contrast, augmentation of GJIC in BC31 cells by forced expression of wild-type Cx43, or a communication-silent mutant, fully suppressed tumorigenicity of these cells. Overall, these results show that cell coupling is a strong, but not the sole, mechanism by which Cx suppresses growth of tumorigenic cells in vivo; a GJIC-independent activity of Cx proteins should be considered as another strong tumor-suppressive factor.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Asamoto M, Takahashi S, Imaida K, Shirai T and Fukushima S. . 1994 Carcinogenesis 15: 2163–2166.

  • Asamoto M, Toriyama-Baba H, Krutovskikh VA, Cohen SM and Tsuda H. . 1998 Jpn. J. Cancer 89: 481–486.

  • Bond SL, Bechberger JF, Khoo NKS and Naus CCG. . 1994 Cell Growth and Differ. 5: 179–186.

  • Brissette JL, Kumar NM, Gilula NB, Hall JE and Dotto GP. . 1994 Proc. Natl. Acad. Sci. USA 91: 6453–6457.

  • Bruzzone R, White TW, Scherer SS, Fischback KH and Paul DL. . 1994 Neuron 13: 1253–1260.

  • Chen Sh-Ch, Pelletier DB, Ao P and Boynton AL. . 1995 Cell Growth and Differ. 6: 681–690.

  • De Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang Ch-Ch and Trosko JE. . 1996 Mol. Carcinog. 16: 203–212.

  • Deschenes SM, Walcott JL, Wexler TL, Scherer SS and Fishbeck KH. . 1997 J. Neurosci. 17: 9077–9084.

  • Donaldson P, Eckert R, Green C and Kistler J. . 1997 Histol. Histopathol. 12: 219–231.

  • Eghbali B, Kessler JA, Reid LM, Roy C and Spray DC. . 1991 Proc. Natl. Acad. Sci. USA 88: 10701–10705.

  • Fitzgerald DJ, Fusenig NE, Boukamp P, Piccoli C, Mesnil M and Yamasaki H. . 1994 Carcinogenesis 15: 1859–1865.

  • Fitzgerald DJ, Knowles SE, Ballard FJ and Murray AW. . 1983 Cancer Res. 43: 3614–3618.

  • Giepmans BNG and Moolenaar WH. . 1998 Curr. Biol. 8: 931–934.

  • Goodenough DA, Paul DL and Jesaitis L. . 1988 J. Cell. Biol. 107: 1817–1824.

  • Hirschi KK, Xu Cheng-en, Tsukamoto T and Sager R. . 1996 Cell Growth and Differ. 7: 861–870.

  • Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL and Boynton AL. . 1998 Cancer Res. 58: 5089–5096.

  • Klann RC, Fitzgerald DJ, Piccoli C, Slaga TJ and Yamasaki H. . 1989 Cancer Res. 49: 699–705.

  • Krutovskikh VA and Yamasaki H. . 1997 Histol. Histopathol. J. 12: 761–768.

  • Krutovskikh VA, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C and Yamasaki H. . 1994 Int. J. Cancer 56: 87–94.

  • Krutovskikh VA, Yamasaki H, Tsuda H and Asamoto M. . 1998 Mol. Carcinog. 23: 254–261.

  • Kumar NM and Gilula NB. . 1996 Cell 84: 381–388.

  • Kumar NM, Friend DS and Gilula NB. . 1995 J. Cell Sci. 108: 3725–3734.

  • Lee WS, Tomasetto C and Sager R. . 1991 Proc. Natl. Acad. Sci. USA 88: 2825–2829.

  • Leube RE. . 1995 J. Cell Sci. 108: 883–894.

  • Loewenstein WR and Kanno Y. . 1966 Nature 209: 1248–1249.

  • Mehta PP, Hotz-Wagenblatt A, Rose B, Shalloway D and Lowenstein WR. . 1991 J. Membr. Biol. 124: 207–225.

  • Merchenthaler I, Stankovics J and Gallyas F. . 1989 J. Histochem. Cytochem. 37: 1563–1565.

  • Mesnil M, Krutovskikh VA, Piccoli C, Elfgang C, Traub O, Willecke K and Yamasaki H. . 1995 Cancer Res. 55: 629–639.

  • Milks LC, Kumar NM, Houghten R, Unwin N and Gilula NB. . 1988 The EMBO J. 7: 2967–2975.

  • Musil LS and Goodenough DA. . 1991 J. Cell Biol. 115: 1357–1374.

  • Naus CCG, Elisevich K, Zhu D, Belliveau DJ and Del Maestro RF. . 1992 Cancer Res. 52: 4208–4213.

  • Neveu MJ, Hully JR, Babcock KL, Hertzberg EL, Nicholson BJ, Paul DL and Pitot H. . 1994 J. Cell Sci. 107: 83–95.

  • Omori Y, Krutovskikh VA, Tsuda H and Yamasaki H. . 1996 Carcinogenesis 17: 2077–2080.

  • Proulx A, Lin ZX and Naus CCG. . 1997 Cell Growth and Differ. 8: 533–540.

  • Rose B, Mehta PP and Lowenstein WR. . 1993 Carcinogenesis 14: 1073–1075.

  • Saito T, Barbin A, Omori Y and Yamasaki H. . 1997 Cancer Res. 57: 376–377.

  • Statuto M, Audebet C, Tonoli H, Selmi-Rubi S, Rousset B and Munari-Silem Y. . 1997 J. Biol. Chem. 272: 24710–24716.

  • Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M and Tada M. . 1998 J. Biol. Chem. 172: 12725–12731.

  • Troyanovsky SM, Troyanovsky RB, Eshkind LG, Krutovskikh VA, Leube RE and Franke WW. . 1994 J. Cell Biol. 127: 151–160.

  • Unwin PNT and Zampighi G. . 1980 Nature 283: 545–549.

  • Yamasaki H. . 1990 Carcinogenesis 11: 1051–1058.

  • Yamasaki H and Naus CC. . 1996 Carcinogenesis 17: 1199–1213.

  • Yeager M and Gilula NB. . 1992 J. Mol. Biol. 223: 929–948.

  • Zhu D, Caveney S, Kidder GM and Naus CCG. . 1991 Proc. Natl. Acad. Sci. USA 88: 1883–1887.

Download references

Acknowledgements

We thank Dr J Cheney for editing the manuscript. This work was supported in part by a grant-in-aid for the Second Term Comprehensive 10-year Strategy for Cancer Control and a grant-in-aid for Cancer Research from the Ministry of Health and Welfare of Japan, a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan and by a grant from the US National Institutes of Health (R01 CA 40534). VA Krutovskikh was a recipient of a fellowship from the Foundation for Promotion of Cancer Research, Tokyo, Japan, when this work was performed.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krutovskikh, V., Troyanovsky, S., Piccoli, C. et al. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 19, 505–513 (2000). https://doi.org/10.1038/sj.onc.1203340

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203340

Keywords

This article is cited by

Search

Quick links